ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Point Mutations in SARS-CoV-2 Variants Induce Long-Range Dynamical Perturbations in Neutralizing Antibodies
This article has 3 authors:Reviewed by ScreenIT
-
Replacement of the Alpha variant of SARS-CoV-2 by the Delta variant in Lebanon between April and June 2021
This article has 26 authors:Reviewed by ScreenIT
-
What has changed in the experiences of people with mental health problems during the COVID-19 pandemic: a coproduced, qualitative interview study
This article has 22 authors:Reviewed by ScreenIT
-
Structural Differences In 3C-like protease (Mpro) From SARS-CoV and SARS-CoV-2: Molecular Insights For Drug Repurposing Against COVID-19 Revealed by Molecular Dynamics Simulations
This article has 6 authors:Reviewed by ScreenIT
-
Prediction of coronavirus 3C-like protease cleavage sites using machine-learning algorithms
This article has 6 authors:Reviewed by ScreenIT
-
Second round statewide sentinel-based population survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India, during January-February 2021
This article has 27 authors:Reviewed by ScreenIT
-
Another step toward final call on Remdesivir efficacy as a treatment for hospitalized COVID-19 patients: a multicenter open-label trial
This article has 15 authors:Reviewed by ScreenIT
-
Broad neutralizing nanobody against SARS-CoV-2 engineered from pre-designed synthetic library
This article has 21 authors:Reviewed by ScreenIT
-
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
This article has 20 authors:Reviewed by ScreenIT
-
The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology: Motivation for Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, its Variants and other Viral Infections
This article has 1 author:Reviewed by ScreenIT